Machine-Learning-Based In-Hospital Mortality Prediction for Transcatheter Mitral Valve Repair in the United States.

Machine-Learning-Based In-Hospital Mortality Prediction for Transcatheter Mitral Valve Repair in the United States.
复制标题

DOI:
10.1016/j.carrev.2020.06.017
复制
发表时间:
2021-01
期刊:
Cardiovascular revascularization medicine : including molecular interventions
影响因子:
--
通讯作者:
Roche-Lima A
Roche-Lima A
中科院分区:
其他
文献类型:
--
作者:
Hernandez-Suarez DF;Ranka S;Kim Y;Latib A;Wiley J;Lopez-Candales A;Pinto DS;Gonzalez MC;Ramakrishna H;Sanina C;Nieves-Rodriguez BG;Rodriguez-Maldonado J;Feliu Maldonado R;Rodriguez-Ruiz IJ;da Luz Sant'Ana I;Wiley KA;Cox-Alomar P;Villablanca PA;Roche-Lima A

文献摘要

参考文献

被引文献

相似文献

Transcatheter mitral valve repair utilization has increased significantly in the United States over the last years. Yet, a risk-prediction tool for adverse events has not been developed. We aimed to generate a machine-learning-based algorithm to predict in-hospital mortality after TMVR. Patients who underwent TMVR from 2012 through 2015 were identified using the National Inpatient Sample database. The study population was randomly divided into a training set (n = 636) and a testing set (n = 213). Prediction models for in-hospital mortality were obtained using five supervised machine-learning classifiers. A total of 849 TMVRs were analyzed in our study. The overall in-hospital mortality was 3.1%. A naïve Bayes (NB) model had the best discrimination for fifteen variables, with an area under the receiver-operating curve (AUC) of 0.83 (95% CI, 0.80–0.87), compared to 0.77 for logistic regression (95% CI, 0.58–0.95), 0.73 for an artificial neural network (95% CI, 0.55–0.91), and 0.67 for both a random forest and a support-vector machine (95% CI, 0.47–0.87). History of coronary artery disease, of chronic kidney disease, and smoking were the three most significant predictors of in-hospital mortality. We developed a robust machine-learning-derived model to predict in-hospital mortality in patients undergoing TMVR. This model is promising for decision-making and deserves further clinical validation.
DOI: 10.1016/j.ijcard.2017.05.067
发表时间: 2017-11-01
影响因子: 3.5
作者:
Shouval, Roni;Hadanny, Amir;Beigel, Roy
通讯作者: Beigel, Roy
DOI: 10.1161/jaha.118.011160
发表时间: 2019-03-05
影响因子: 5.4
作者:
Al'Aref, Subhi J.;Singh, Gurpreet;Minutello, Robert M.
通讯作者: Minutello, Robert M.
DOI: 10.1093/eurheartj/ehv627
发表时间: 2016-02-21
影响因子: 39.3
作者:
Puls M;Lubos E;Boekstegers P;von Bardeleben RS;Ouarrak T;Butter C;Zuern CS;Bekeredjian R;Sievert H;Nickenig G;Eggebrecht H;Senges J;Schillinger W
通讯作者: Schillinger W
DOI: 10.1161/circinterventions.117.006179
发表时间: 2018-04-01
影响因子: 5.6
作者:
Gupta, Tanush;Khera, Sahil;Bhatt, Deepak L.
通讯作者: Bhatt, Deepak L.
DOI: 10.1097/00005650-199801000-00004
发表时间: 1998-01-01
期刊: MEDICAL CARE
影响因子: 3
作者:
Elixhauser, A;Steiner, C;Coffey, RN
通讯作者: Coffey, RN